Funding rounds

1 company funding rounds disclosed in the daily RiseFinder box for 19 October 2026.

Period: Daily
Window: 1d
Rows: 1
Data through: 19 October 2026

← All current risers All funding rounds editions Older: 18 October 2026

01/

Daily box

1 entry

Immorta Bio, Inc.

On its website, the company describes its work as “Technologies Seno Vax™ Autologous Approach To Eliminate Senescent Cells More About SenoVax™ StemCell Revivify™ Rebuild Damaged Organs and Tissues With Stem Cells More About StemCellRevivify™…”. Its SEC Form D filed on 2026-10-16 reports US$612,503 in securities sold, with a first sale date of 2024-11-05. The amount reflects the securities sales disclosed by the company in this offering at the filing date; it is separate from the offering's target amount and from measures of product traction.

SEC Form D

Open source ↗

$613k

$613k of $5.0m target

This dated edition is generated from the reviewed RiseFinder export. Movement figures retain their original source, period and direction.

Get early signals on the websites, apps, repositories and startups gaining momentum. Join the list for Risefinder email briefings.

By subscribing, you ask us to store your email and send Risefinder updates. You can unsubscribe at any time. Privacy.

Want a sample first? Read past daily emails.

Funding rounds

Daily box

Immorta Bio, Inc.

Get email updates